Singapore, Singapore

Oleksandr Gromenko


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Oleksandr Gromenko and His Impact on Respiratory Therapy Compliance**

Introduction

Oleksandr Gromenko is an accomplished inventor based in Singapore, renowned for his contribution to the field of respiratory therapy. With a focus on enhancing user compliance, his innovations have the potential to significantly improve health outcomes for patients utilizing respiratory devices.

Latest Patents

Gromenko holds a patent for the "Prediction of respiratory therapy compliance," which includes systems and methods designed to increase user adherence to respiratory therapy devices. This innovative technology monitors usage data from respiratory therapy devices, analyzing trends to predict when users might discontinue or decrease their usage within a specified time frame. By flagging users at risk of non-compliance, the system can trigger automated interventions to encourage continued engagement with the therapy, ultimately aiming to enhance patient outcomes.

Career Highlights

Currently, Oleksandr Gromenko is affiliated with ResMed Pty Ltd, a leading company in the development of equipment related to sleep and respiratory disorders. His work at ResMed showcases his dedication to improving healthcare technologies through innovative solutions that cater to patient needs.

Collaborations

Throughout his career, Gromenko has collaborated with talented professionals such as Nathan Liu and Sakeena De Souza. These collaborations have fostered a creative environment that promotes the advancement of new ideas within the respiratory therapy sector, enhancing the effectiveness of therapeutic interventions for patients.

Conclusion

Oleksandr Gromenko's pioneering work in respiratory therapy compliance is a testament to the impact innovators can make in the healthcare industry. Through his patent and collaborative efforts at ResMed, Gromenko continues to lead the charge in developing technologies that enhance patient adherence and improve overall health outcomes. His contributions reflect not only his technical expertise but also his commitment to bettering the lives of individuals relying on respiratory therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…